• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估血小板输注与基于证据的血小板指南的适宜性:57 家医院的血小板输注审核。

Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals.

机构信息

Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

University of St Andrews, Fife, UK.

出版信息

Transfusion. 2021 Jan;61(1):57-71. doi: 10.1111/trf.16134. Epub 2020 Oct 20.

DOI:10.1111/trf.16134
PMID:33078852
Abstract

BACKGROUND

Platelet transfusions are used to prevent or control bleeding in patients with thrombocytopenia or platelet dysfunction. The pretransfusion platelet count threshold has been studied extensively in multiple patient settings yielding high-quality evidence that has been summarized in several comprehensive evidence-based platelet guidelines.

STUDY DESIGN AND METHODS

A prospective 12-week audit of consecutive platelet transfusions using validated and evidence-based adjudication criteria was conducted. Patient demographic, laboratory, and transfusion details were collected with an electronic audit tool. Each order was adjudicated either electronically or independently by two transfusion medicine physicians. The aim was to determine platelet transfusion appropriateness and common scenarios with deviations from guidelines.

RESULTS

Fifty-seven (38%) of 150 hospitals provided data on 1903 platelet orders, representing 90% of platelet usage in the region during the time period. Overall, 702 of 1693 adult (41.5%) and 133 of 210 pediatric orders (63.3%) were deemed inappropriate. The most common inappropriate platelet order was for prophylaxis in the absence of bleeding or planned procedure in patients with hypoproliferative thrombocytopenia and a platelet count over 10 x 10 /L (53% of inappropriate orders in adults and 45% in pediatrics). Platelet transfusions ordered with either a preprinted transfusion order set (odds ratio [OR], 1.97; 95% confidence interval [CI], 1.44-2.73) or technologist prospective screening (OR, 1.40; 95% CI, 1.10-1.78) were more likely to be appropriate.

CONCLUSION

There is a discrepancy between clinical practice and evidence-based platelet guidelines. Broad educational and system changes will be needed to align platelet transfusion practice with guideline recommendations.

摘要

背景

血小板输注用于预防或控制血小板减少症或血小板功能障碍患者的出血。在多种患者环境中,已经广泛研究了输血前血小板计数阈值,产生了高质量的证据,并在几个基于证据的综合血小板指南中进行了总结。

研究设计和方法

对连续血小板输注进行了为期 12 周的前瞻性审核,使用了经过验证和基于证据的裁决标准。使用电子审核工具收集患者的人口统计学、实验室和输血详细信息。每个订单都通过电子方式或由两名输血医学医师独立裁决。目的是确定血小板输血的适宜性以及与指南偏离的常见情况。

结果

57 家(38%)150 家医院提供了 1903 个血小板订单的数据,代表了该地区在此期间血小板使用量的 90%。总体而言,1693 个成人(41.5%)中的 702 个和 210 个儿科(63.3%)订单被认为是不适当的。最常见的不适当血小板订单是在无出血或计划手术的情况下,对增生性血小板减少症和血小板计数超过 10×10/L 的患者进行预防(成人中 53%的不适当订单和儿科中 45%)。使用预印输血医嘱集(比值比 [OR],1.97;95%置信区间 [CI],1.44-2.73)或技术员前瞻性筛查(OR,1.40;95%CI,1.10-1.78)下达的血小板输注更可能是适当的。

结论

临床实践与基于证据的血小板指南之间存在差异。需要广泛的教育和系统改变,以使血小板输血实践与指南建议保持一致。

相似文献

1
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals.评估血小板输注与基于证据的血小板指南的适宜性:57 家医院的血小板输注审核。
Transfusion. 2021 Jan;61(1):57-71. doi: 10.1111/trf.16134. Epub 2020 Oct 20.
2
Audit of appropriate use of platelet transfusions: validation of adjudication criteria.血小板输注合理使用情况的审核:裁决标准的验证
Vox Sang. 2018 Jan;113(1):40-50. doi: 10.1111/vox.12550. Epub 2017 Oct 19.
3
A clinical audit on the practice of platelet transfusions at a tertiary paediatric referral centre.在一家三级儿科转诊中心进行的血小板输注实践临床审计。
Malays J Pathol. 1998 Jun;20(1):35-40.
4
An audit of platelet transfusion within the Wellington Cancer Centre.惠灵顿癌症中心的血小板输注审核。
Intern Med J. 2012 Jan;42(1):65-70. doi: 10.1111/j.1445-5994.2010.02358.x.
5
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.预防性血小板输注用于预防血液系统疾病患者化疗和干细胞移植后的出血。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3.
6
Platelet utilization and the transfusion trigger: a prospective analysis.血小板的使用与输血触发因素:一项前瞻性分析。
Transfusion. 2007 Feb;47(2):201-5. doi: 10.1111/j.1537-2995.2007.01089.x.
7
The appropriateness of platelet transfusions in hematological patients and the potential for improvement.血液学患者血小板输注的适宜性及改善潜力。
Transfus Clin Biol. 2023 May;30(2):212-218. doi: 10.1016/j.tracli.2022.11.007. Epub 2022 Dec 7.
8
Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry.重症监护病房中的血小板输注实践:来自大型输血登记处的数据。
Chest. 2016 Sep;150(3):516-23. doi: 10.1016/j.chest.2016.04.004. Epub 2016 Apr 19.
9
Standardization of prophylactic platelet transfusion dosing in a pediatric oncology population: a quality improvement project.儿科肿瘤患者预防性血小板输注剂量的标准化:一项质量改进项目。
Transfusion. 2018 Dec;58(12):2836-2840. doi: 10.1111/trf.14924. Epub 2018 Sep 27.
10
Pediatric Plasma and Platelet Transfusions on Extracorporeal Membrane Oxygenation: A Subgroup Analysis of Two Large International Point-Prevalence Studies and the Role of Local Guidelines.儿科体外膜肺氧合患者的血浆和血小板输注:两项大型国际时点患病率研究的亚组分析及当地指南的作用。
Pediatr Crit Care Med. 2020 Mar;21(3):267-275. doi: 10.1097/PCC.0000000000002160.

引用本文的文献

1
The clinical use of platelet transfusions: A systematic literature review and meta-analysis on behalf of the International Collaboration for Transfusion Medicine Guidelines.血小板输注的临床应用:代表输血医学指南国际协作组进行的系统文献综述和荟萃分析。
Transfusion. 2025 Jun;65(6):1155-1169. doi: 10.1111/trf.18277. Epub 2025 May 29.
2
How do we leverage implementation science to support and accelerate uptake of clinical practice guidelines in transfusion medicine.我们如何利用实施科学来支持和加速输血医学临床实践指南的采用?
Transfusion. 2025 May;65(5):799-813. doi: 10.1111/trf.18234. Epub 2025 Apr 8.
3
Plasma proteomes of acute myeloid leukemia patients treated with transfusions reveal signatures of inflammation and hemostatic dysregulation.
接受输血治疗的急性髓系白血病患者的血浆蛋白质组揭示了炎症和止血失调的特征。
Transl Med Commun. 2024;9(1):27. doi: 10.1186/s41231-024-00189-5. Epub 2024 Sep 9.
4
Platelet HLA gene bank digital matching technology for platelet transfusion refractory patients with malignant tumors: a case report.血小板HLA基因库数字匹配技术用于恶性肿瘤血小板输注无效患者:一例报告
Front Oncol. 2024 Sep 26;14:1419485. doi: 10.3389/fonc.2024.1419485. eCollection 2024.
5
Correlation of the Transfusion Camp knowledge assessment test with clinical transfusion practice.输血知识评估测试与临床输血实践的相关性
Transfusion. 2024 Dec;64(12):2371-2379. doi: 10.1111/trf.18035. Epub 2024 Oct 1.
6
Let Us Know Transfusion Triggers for Prophylactic Use of Platelet Concentrate-Analysis of Compliance with Recent Transfusion Guidelines in a Large Academic Medical Center.让我们了解预防性使用血小板浓缩物的输血触发因素——对一家大型学术医疗中心近期输血指南依从性的分析
J Clin Med. 2023 Sep 10;12(18):5885. doi: 10.3390/jcm12185885.
7
The Usability of Platelet Mass Index Thresholds to Assess the Repeated Platelet Transfusion Requirements in Neonates.血小板质量指数阈值用于评估新生儿反复血小板输注需求的可用性
Indian J Hematol Blood Transfus. 2023 Jul;39(3):464-469. doi: 10.1007/s12288-022-01604-3. Epub 2022 Nov 8.
8
Evidence-Based Minireview: Strategies to manage a severely HLA-alloimmunized patient with refractory thrombocytopenia.循证医学小型综述:管理一名患有难治性血小板减少症的严重HLA同种免疫患者的策略
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):437-441. doi: 10.1182/hematology.2022000416.